Galapagos NV Cash Conversion Cycle 2011-2026 | GLPG

Annual Cash Conversion Cycle Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	67.1	-25.1	-173	-76.8	-

All numbers in EUR currency

Maximum	Minimum	Average
67.1	-173	-51.8

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Alnylam Pharmaceuticals ALNY	46.6	$ 326.45	-2.08 %	$ 42.8 B	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Amphastar Pharmaceuticals AMPH	205	$ 21.85	0.78 %	$ 1.02 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	-1.83 K	-	-5.16 %	$ 5.39 M	USA
Akebia Therapeutics AKBA	42	$ 1.4	-10.0 %	$ 360 M	USA
Aquestive Therapeutics AQST	-172	$ 4.22	-0.5 %	$ 451 M	USA
Arcutis Biotherapeutics ARQT	158	$ 23.98	-2.44 %	$ 3.05 B	USA
Grifols, S.A. GRFS	0.000171	$ 8.58	-1.29 %	$ 6.83 B	Spain
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	119	$ 1.53	2.35 %	$ 407 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	-1.67 K	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	-3.74 K	$ 33.75	-0.35 %	$ 2.24 B	USA
bluebird bio BLUE	-54.4	-	-	$ 546 M	USA